Cargando…
High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes
INTRODUCTION: A very narrow therapeutic window exists when delivering curative chemoradiotherapy for inoperable locally advanced non-small cell lung cancer (NSCLC), particularly when large distances exist between areas of gross disease in the thorax. In the present study, we hypothesize that a novel...
Autores principales: | Eichkorn, Tanja, Lischalk, Jonathan W., Stüwe, Cedric, Tonndorf-Martini, Eric, Schubert, Kai, Dinges, Lisa-Antonia, Regnery, Sebastian, Bozorgmehr, Farastuk, König, Laila, Christopoulos, Petros, Hörner-Rieber, Juliane, Adeberg, Sebastian, Herfarth, Klaus, Winter, Hauke, Thomas, Michael, Rieken, Stefan, Debus, Jürgen, El Shafie, Rami A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880536/ https://www.ncbi.nlm.nih.gov/pubmed/36713565 http://dx.doi.org/10.3389/fonc.2022.1035370 |
Ejemplares similares
-
Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
por: Eichkorn, Tanja, et al.
Publicado: (2021) -
Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer—Cross-Sectional Study of Eligibility and Administration Rates
por: Eichkorn, Tanja, et al.
Publicado: (2020) -
Progression of Pulmonary Function and Correlation with Survival Following Stereotactic Body Radiotherapy of Central and Ultracentral Lung Tumors
por: Regnery, Sebastian, et al.
Publicado: (2020) -
Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy
por: Bernhardt, Denise, et al.
Publicado: (2018) -
Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy
por: Fink, Christoph A., et al.
Publicado: (2023)